Urinary Incontinence Therapeutics Market
The urinary incontinence therapeutics market is estimated to increase from US$4.4 Bn in 2024 to US$5.8 Bn by 2031. The market is projected to record a CAGR of 4.1% during the forecast period from 2024 to 2031. In 2023, the U.S. urinary incontinence therapeutics market captured a substantial portion of the North America market, driven by the widespread prevalence of the condition, which affects millions of adults.